Evidence accumulated in recent years indicate that, in addition to its capacity to govern cell cycle progression, p53 activation has also a major impact on metabolic processes, including glucose transport [48] and obesity [49]. This evidence concerns the gene TP53 and obesity due to melanocortin 4 receptor deficiency.